-
dedup_wf_001--47394909f07621b8018b79392e4f20ad
Additional file 2: Figure. S2. Effect of calcium on TCRPs of human respiratory epithelial cells. -
dedup_wf_001--c833844825abc3e0905574f035f979b6
Interleukin (IL)-17A may be an underlying factor in the pathophysiology of chronic obstructive pulmonary disease (COPD). Anti-IL-17 monoclonal antibodies have been used... -
dedup_wf_001--da27e0a2dc14066e78e0c3440fdc2e6a
Full model description and additional supplementary Figure S1-S6. This document includes a complete model description, including parameters, assumptions, mathematical... -
Assessing amyotrophic lateral sclerosis prevalence in Norway from 2009 to 201...
Objective: In Norway, diagnoses from specialist health care visits, drug prescriptions, and causes of deaths are registered in compulsory health registers. We aimed to determine... -
MOESM1 of Prevalence of nasal colonization by methicillin-resistant Staphyloc...
Additional file 1: Table S1. Association of MRSA and MSSA positivity according to HIV-related habits and HIV-related factors seen at the HC/UFPE DIP Service. -
dedup_wf_001--1f58cdc61c7ffb3ead7f7914837795f8
To investigate the optimal dosage/regimen and to evaluate the efficacy and safety of albiglutide in Japanese patients with type 2 diabetes mellitus. This was a randomized,... -
Additional file 1 of EAACI Task force Clinical epidemiology of anaphylaxis: e...
Additional file 1. Questionnaire. -
dedup_wf_001--29372b5ef5fe657bdbd5597583a227cf
Amyotrophic lateral sclerosis (ALS) is a rapidly progressive fatal neurodegenerative disease affecting one in 350 people. The aim of Project MinE is to elucidate the... -
Additional file 3: of A prospective phase I dose-escalation trial of stereota...
Table S1. Target Dose and Volume Data by Individual Patient. CTV- clinical target volume; PTV-I – initial planning target volume; PTF-F – final planning target volume; NR – not... -
MOESM1 of The impact of data quality and source data verification on epidemio...
Additional file 1: Table S1. Complete list of study variables with descriptions. Table S2. Overview of audit frequency by site. Figure S1. Summary of reported audit findings for... -
dedup_wf_001--139623b0ce6e2a116d48d741c1f77d72
Additional file 1. Questionnaire: â The prevalence of hypertension in HIV/AIDS patients on antiretroviral therapy compared with art-naĂŻve patients at the Limbe regional... -
dedup_wf_001--e18af660f5c7b25d35e1ad8ecee0eae7
Figure S1 Coverage profiles of antisense transcripts. Figure S2 Validation of antisense transcripts. Figure S3 Antisense transcripts with PAA, knockout virus, and HSV-2... -
Additional file 1: of A randomized, clinical trial to assess the relative eff...
List of Ethics Committees. (DOCX 27 kb) -
dedup_wf_001--ea39bd379f9e6bdecff1f821229c38ab
Additional file 9. Overview of the gastric bacterial richness, diversity and evenness of the bambermycin-supplemented and non-supplemented groups. Gastric bacterial richness... -
Additional file 1: of Teen clinics: missing the mark? Comparing pregnancy and...
Table S1: ICD-9 and ICD-10 codes used to define pregnancies. Table S2: Crude pregnancy and sexually transmitted infections rates, by enrolled/non-enrolled group and income... -
Additional file 1: of PU.1 regulates Alzheimerâ s disease-associated genes in...
Table S1. List of cases. List of cases used for all studies. (DOCX 19 kb) -
Additional file 2: Table S1. of Economic burden and its associated factors of...
Generalized linear models (Gamma with log link) selection. (DOCX 30 kb) -
Additional file 1 of Benefits of glycopyrrolate/formoterol fumarate metered d...
Additional file: 1 File S1. Results – safety. Table S1. Moderate or severe COPD annualized exacerbations rate (pooled ITT, exacerbation history, and CAT ≥15 populations). Table... -
MOESM1 of Effects of chloride content of intravenous crystalloid solutions in...
Additional file 1: Table S1. Sensitivity analysis of the effects of chloride content in crystalloid fluid on critically ill patientsâ outcomes. Figure S1. a Risk of bias graph.... -
The ribonuclease activity of Csm6 is required for anti-plasmid immunity by Ty...
CRISPR-Cas systems provide prokaryotes with RNA-based adaptive immunity against viruses and plasmids. A unique feature of Type III CRISPR-Cas systems is that they selectively...
